Latest Breaking News On - Coordinator of the national coordinating reference center - Page 1 : comparemela.com

PureTech Announces Annual Results for Year Ended December 31, 2021 – Consumer Electronics Net

PureTech Announces Annual Results for Year Ended December 31, 2021 – Consumer Electronics Net
consumerelectronicsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from consumerelectronicsnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBill bradfordClaude bernard lyonToby maherMarlies wijsenbeekRob winderBen atwellVincent cottinGelesi plenityPaul fordDaphne zoharPaul nobleAkili endeavorrxKevin flahertyJulie krop

PureTech Announces Annual Results for Year Ended December 31, 2021

PureTech Announces Annual Results for Year Ended December 31, 2021 - read this article along with other careers information, tips and advice on BioSpace

New yorkUnited statesHong kongUnited kingdomCity ofSan franciscoUniversity of southern californiaBill bradfordAli bauerleinToby maherMichael davinVincent cottinEli lillyBharatt chowriraSimona leviTom wiggans

PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders

PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders Leading experts in the field will advise on clinical development of PureTech’s lead, wholly-owned product candidate, LYT-100, in idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lu.

United statesBill bradfordClaude bernard lyonMarlies wijsenbeekToby maherVincent cottinDaphne zoharPaul nobleKevin flahertySinai medical centerGenentech incUniversity of michiganPuretech healthCoordinator of the national coordinating reference centerErasmus medical centerDepartment of medicine

PureTech Health plc: PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders

PureTech Health plc: PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ( PureTech or the Company ), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced the formation of its Clinical Advisory Board for idiopathic pulmonary fibrosis (IPF) and other progressive fibrosing interstitial lung diseases (PF-ILDs). Comprised of physicians and researchers with deep expertise in the clinical development of novel therapies in PF-ILDs, the advisory group will work closely with PureTech as it advances LYT-100 (deupirfenidone).

United statesBill bradfordClaude bernard lyonMarlies wijsenbeekToby maherVincent cottinAllison mead talbotDaphne zoharStephanie simonPaul nobleKevin flahertySinai medical centerGenentech incUniversity of michiganPuretech healthCoordinator of the national coordinating reference center